Chronobiology of cardiovascular and pulmonary disease
心血管和肺部疾病的时间生物学
基本信息
- 批准号:8536929
- 负责人:
- 金额:$ 18.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-20 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic beta-AntagonistsAdverse eventAffectAgeAgingArousalAsthmaAutonomic nervous systemBehaviorBehavior TherapyBehavioralBicyclingBiologicalBiological ClocksBiological MarkersBlood PlateletsBlood PressureBlood VesselsBody TemperatureCardiacCardiovascular DiseasesCardiovascular systemCenter for Translational Science ActivitiesCerebrovascular CirculationCerebrumCessation of lifeChronobiologyCircadian RhythmsClinicalClinical InvestigatorClinical SciencesDiseaseElderlyEnvironmentEpidemiologic StudiesEpidemiologyEpinephrineEquilibriumEventExerciseExertionExhibitsFacultyFrequenciesFundingFutureGoalsHeart DiseasesHeart RateHemostatic AgentsHomeostasisHospitalsHourHumanHydrocortisoneHypothalamic structureImpedance CardiographyIndividualInterventionJet Lag SyndromeLaboratoriesLeadLife StyleLung diseasesMeasuresMedicalMedicineMelatoninMentorsModificationMyocardial InfarctionNeurobiologyNeurocognitiveNeuronsObesityOutcomePatternPharmaceutical PreparationsPhasePhysiologic MonitoringPhysiologicalPhysiological AdaptationPlayPopulationPostureProtocols documentationPsyche structureRegulationResearchResearch PersonnelRisk FactorsRisk MarkerRoleScheduleSecondary toSeveritiesSeverity of illnessSiteSleepSleep Wake CycleSocietiesStressStrokeStructureSystemTherapy Clinical TrialsTimeTissuesTraining ProgramsUnited StatesUnited States National Institutes of HealthUniversitiesVariantVentricular ArrhythmiaVulnerable PopulationsWomanWorkage effectbasebehavior influencecardiovascular disorder therapycardiovascular risk factorcircadian behavioral rhythmscircadian pacemakerclinically relevantdensityhemodynamicsimprovedmortalityprimary outcomeprogramsresearch facilityresearch studyrespiratoryresponsesecondary outcomesedentaryshift workstressorsudden cardiac deathsuprachiasmatic nucleus
项目摘要
The applicant has a funded research program in medical chronoblology, is Associate Director of an NIH funded Harvard-wide Training Program in Sleep, Circadian & Respiratory Neurobiology, and has an excellent track record and commitment to mentoring clinical researchers using where appropriate the formal structure provided by this Training Program. The candidate's goal is to develop a group of outstanding clinical investigators of medical chronoblology - to understand the circadian and sleep/wake mechanisms underlying the day/night pattern in the severity of a number of disorders. The environment for this research is outstanding, with over 60 successful research faculty involved with the Harvard-wide Division of Sleep Medicine. There are 'state of the art' research facilities, comprising intensive physiological monitoring suites in Harvard University's Clinical and Translational Science Center (CTSC) at the Brigham & Women's Hospital site. The candidate has current research funding to determine the role of the body clock versus behaviors on cardiovascular risk markers in healthy young subjects. To understand the clinical relevance of this work, the candidate wishes to extend these studies to examine more vulnerable populations, such as elderly, sedentary, obese and hypertensive individuals. In these groups, epidemiological studies have revealed a high frequency of adverse cardiovascular events around 10 AM. To study such effects, a "Forced Desynchrony" protocol will be used, wherein subjects' behaviors occur at all phases of the circadian cycle. The aims are to determine the effect upon cardiovascular risk markers of the intrinsic circadian rhythm (independent from behaviors) and any interaction between the circadian system and behavioral stressors, including postural changes, exercise and mental stress. Cardiovascular markers of vulnerability include autonomic nervous system measures, cerebral blood flow autoregulation, platelet aggregability and endothelial function. It is anticipated that standard behavioral stressors (standardized changes in posture, activity or sleep/wake state) will have different effects at specific phases of the circadian cycle - revealing vulnerable phases of the circadian system for certain behaviors. The applicant's longer term goals will be to improve therapy in such disorders via modifications in behavior or chronopharmacology.
申请人有一个资助的研究项目在医学年表,是美国国立卫生研究院资助的哈佛大学睡眠,昼夜节律和呼吸神经生物学培训计划的副主任,并有良好的业绩记录和承诺,指导临床研究人员在适当的情况下使用该培训计划提供的正式结构。候选人的目标是培养一批杰出的医学时间表临床研究人员-了解昼夜节律和睡眠/觉醒机制,这些机制是许多疾病严重程度的日/夜模式的基础。这项研究的环境是杰出的,有60多名成功的研究人员参与了哈佛大学睡眠医学部。有“最先进的”研究设施,包括在布莱根妇女医院的哈佛大学临床和转化科学中心(CTSC)的密集的生理监测套房。候选人目前有研究资金来确定健康年轻受试者的生物钟与心血管风险标志物行为的作用。为了了解这项工作的临床相关性,候选人希望将这些研究扩展到更脆弱的人群,如老年人,久坐不动,肥胖和高血压患者。在这些人群中,流行病学研究揭示了上午10点左右不良心血管事件的高频率。为了研究这种影响,将使用“强迫性强迫性”方案,其中受试者的行为发生在昼夜节律周期的所有阶段。目的是确定内在昼夜节律(独立于行为)对心血管风险标志物的影响以及昼夜节律系统与行为应激源(包括姿势变化、运动和精神压力)之间的任何相互作用。脆弱性的心血管标志物包括自主神经系统测量、脑血流自动调节、血小板聚集性和内皮功能。预期标准行为应激源(姿势、活动或睡眠/清醒状态的标准化变化)将在昼夜节律周期的特定阶段具有不同的影响-揭示昼夜节律系统对于某些行为的脆弱阶段。申请人的长期目标将是通过行为或时间药理学的改变来改善此类疾病的治疗。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Decreased sleep in heart failure: are medications to blame?
心力衰竭导致睡眠减少:药物是罪魁祸首吗?
- DOI:10.1001/archinte.167.10.1098-b
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Scheer,FrankAJL;Stone,PeterH;Shea,StevenA
- 通讯作者:Shea,StevenA
Noninvasive fractal biomarker of clock neurotransmitter disturbance in humans with dementia.
- DOI:10.1038/srep02229
- 发表时间:2013
- 期刊:
- 影响因子:4.6
- 作者:Hu, Kun;Harper, David G.;Shea, Steven A.;Stopa, Edward G.;Scheer, Frank A. J. L.
- 通讯作者:Scheer, Frank A. J. L.
Brachial artery endothelial function is stable across the morning in young men.
- DOI:10.1186/s12947-015-0036-1
- 发表时间:2015-10-05
- 期刊:
- 影响因子:1.9
- 作者:Thosar SS;Wiggins CC;Shea SA;Wallace JP
- 通讯作者:Wallace JP
Influence of the Circadian System on Disease Severity.
- DOI:10.1016/j.jsmc.2009.02.005
- 发表时间:2009-06-01
- 期刊:
- 影响因子:2.8
- 作者:Litinski, Mikhail;Scheer, Frank Ajl;Shea, Steven A
- 通讯作者:Shea, Steven A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN A SHEA其他文献
STEVEN A SHEA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN A SHEA', 18)}}的其他基金
Endogenous circadian mechanisms underlying cardiovascular risk
心血管风险的内源性昼夜节律机制
- 批准号:
10438560 - 财政年份:2021
- 资助金额:
$ 18.01万 - 项目类别:
Endogenous circadian mechanisms underlying cardiovascular risk
心血管风险的内源性昼夜节律机制
- 批准号:
10656183 - 财政年份:2021
- 资助金额:
$ 18.01万 - 项目类别:
Sleep and Circadian Mechanisms Contributing to Disparity in Prevalence of Hypertension between Black and White Americans
睡眠和昼夜节律机制导致美国黑人和白人之间高血压患病率的差异
- 批准号:
9921998 - 财政年份:2018
- 资助金额:
$ 18.01万 - 项目类别:
Sleep and Circadian Mechanisms Contributing to Disparity in Prevalence of Hypertension Between Black and White Americans
睡眠和昼夜节律机制导致美国黑人和白人之间高血压患病率的差异
- 批准号:
9921461 - 财政年份:2018
- 资助金额:
$ 18.01万 - 项目类别:
Circadian Mechanisms in Progression of Obstructive Apnea in Humans
人类阻塞性呼吸暂停进展的昼夜节律机制
- 批准号:
7589472 - 财政年份:2009
- 资助金额:
$ 18.01万 - 项目类别:
Circadian Mechanisms in Progression of Obstructive Apnea in Humans
人类阻塞性呼吸暂停进展的昼夜节律机制
- 批准号:
7841754 - 财政年份:2009
- 资助金额:
$ 18.01万 - 项目类别:
Chronobiology of cardiovascular and pulmonary disease
心血管和肺部疾病的时间生物学
- 批准号:
6909786 - 财政年份:2004
- 资助金额:
$ 18.01万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 18.01万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 18.01万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 18.01万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 18.01万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 18.01万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 18.01万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 18.01万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 18.01万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 18.01万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 18.01万 - 项目类别:














{{item.name}}会员




